MyBio Europe retweeted
Huge congratulations to our 2nd Year Symposium Winners Shauna McClelland, Scott Monteith and Timothy O’Brien! The standard was high across the board! A huge thanks to @MyBioLtd for sponsoring a really engaging day!
MyBio Europe retweeted
Expanding the NGS toolkit for cancer detection: Twist’s NGS solutions put new biomarkers and better diagnostics within reach
#BloodCancerAwarenessMonth @TwistBioscience
Expanding Liquid Biopsy and DNA Sequencing tools | Twist Bioscience bit.ly/3sF2YB0
MyBio Europe retweeted
Target capture meets long-read sequencing! The #TwistBlog highlights how long-read panels make it possible for researchers to fill the gaps left by short-read sequencing & shine light on the human genome’s structural complexity.
@PacBio @TwistBioscience
bit.ly/45wbO2E
MyBio Europe retweeted
Modular, CRISPR-free base editing system, which called CyDENT, achieves effective base editing in the nucleus, mitochondria and chloroplast genomes of plant and human cells.
@GaoCaixiaLab @physorg_com
bit.ly/3YVMCjo
MyBio Europe retweeted
Using modern biological tools, researchers engineered #cancer cells with and without specific chromosome abnormalities, showing how tumors rely on them for survival and clarifying the biological role of aneuploidy.
Learn more this week in Science: scim.ag/3QC
MyBio Europe retweeted
A collaborative group led by Trinity researchers has published the first guidelines for treating patients with severe community-acquired #pneumonia (sCAP) – a high-mortality condition that describes people admitted to #ICU Read more here: tcd.ie/news_events/top-stori… #TrinityResearch
MyBio Europe retweeted
🎙️PODCAST🎙️ Listen here: bit.ly/3Dwy4dL
"Can mutations be turned into treatment options?"
@Dcollinsflynn, Clinical Lead for the Molecular Tumour Board talks about Next Generation sequencing and more with @EibhlinMulroe, Tanya Knott of @SJK_Foundation & @cancertrials_ie's Claire Bermingham.
@McVeighTerri @rdientsmann @Seamusoreilly18 @RayMcDermott1
MyBio Europe retweeted
One in five people who contract the COVID-19 virus don’t get sick. A gene variant may explain why. @NewsfromScience @ScienceMagazine
One in five people who contract the COVID-19 virus don’t get sick. A gene variant may explain why | Science | AAAS bit.ly/3ODDawk
MyBio Europe retweeted
Unleashing the Power of RNA-seq: Optimizing with Twist Solutions. Using quality library prep, well-designed target capture, & simple workflows, RNA-seq can become just another unremarkable process that produces remarkable data.
#TwistBlog @TwistBioscience
bit.ly/45B3pui
MyBio Europe retweeted
The @TwistBioscience 2023 ESG report is hot off the press, and it’s good…
🧬 1 Twist-produced gene = driving a gas car 0.092 miles
🧬 1 Standard 96-well plate gene = driving a gas car 59 miles.
Read all the stats: investors.twistbioscience.co…
MyBio Europe retweeted
Looking for a new science podcast? Check out @GrinsteinJ’s "The Leading Strand” featuring candid conversations with pioneers of biotechnology.
With a logo like that 🧬, we couldn’t help but share!
@LiebertPub
The Leading Strand | Podcast on Spotify spoti.fi/3OO2Whx
MyBio Europe retweeted
We couldn’t agree more! Our 2023 ESG report was published earlier this week– our glove recycling, plastic recycling, greener containers, and lower carbon footprint & chemical use for producing genes is quantified. Read our report: bit.ly/3KRUNHO
go.nature.com/3KUE5Yd
MyBio Europe retweeted
A DNA-Based Anticoagulant is Set to Disrupt the Norm
@SynBioBeta
bit.ly/44mMuuE
MyBio Europe retweeted
A major new study - published this evening in
@Nature- led by @NollaigBourke @TrinityMed1
& @pjhpauljh @Hudson_Research suggests the anti-tumour activities of an immune protein may stop ovarian cancer growth. More: tcd.ie/news_events/top-stori…
#ovariancancer #TrinityResearch
MyBio Europe retweeted
📢🎙️PODCAST🎙️: bit.ly/3Dwy4dL
Learn about pancreatic cancer - and how the Pat Smullen Fund in @cancertrials_ie, the 🏇racing community, and other donors, are changing the face of pancreatic cancer trials in 🇮🇪
@francescrowley @EibhlinMulroe @graokane @RayMcDermott1
MyBio Europe retweeted
Dreading that colonoscopy? In the future, it might look more like drinking a yogurt smoothie of bioengineered bacteria that can detect cell-free DNA shed by tumors in close proximity to those tumors. @danworthley @jeffhasty_UCSD @ponderingsci
@GENbio
bit.ly/3P06kqX
MyBio Europe retweeted
🧬@TwistBioscience libraries hard at work! From @DennisRBurton & team at @scrippsresearch: “Broadening a SARS-CoV-1–neutralizing #antibody for potent SARS-CoV-2 neutralization through directed evolution.”
Thank you for choosing Twist to support this work
bit.ly/3R0KC7V
MyBio Europe retweeted
Phenomenal read by @SilverJacket in the @NewYorker. A scientific rescue mission aims to analyze every plant, animal, and fungus before it’s too late. @EBPgenome @OsbornLab @PacBio
The Race to Save the World’s DNA | The New Yorker bit.ly/45aytl1
MyBio Europe retweeted
Custom proteins that can switch between two fully structured conformations! By coupling this molecular motion with a binding event, these proteins serve as biological counterparts to electronic transistors. @UWproteindesign @FloPraetorius, @proleu
bit.ly/3OLgzhu
MyBio Europe retweeted
Amazing work from @dsgoodsell













